Is Strata Markets Safe?
Risk Grade: C (43/100)
Strata Markets is rated as elevated risk — multiple novel mechanisms and notable interaction risks.
Elevated risk — novel perpetual tranching with single yield source creates concentrated risk, partially offset by transparent structured product design and growing TVL.
Strata Markets is a perpetual yield tranching protocol that splits Ethena's USDe yield into senior and junior tranches with $150M TVL. Its C grade reflects novel perpetual tranching mechanics without maturity dates, direct dependency on Ethena's USDe as sole yield source, and early-stage protocol risk with only $3M in seed funding.
TVL
$240M
Mechanisms
5
Interactions
4
Value Grade
D-
Key Risks for Strata Markets Users
All yield comes from Ethena's USDe. If funding rates go negative for extended periods, junior tranche holders absorb all losses and could lose their entire investment.
Unlike traditional structured products, Strata's perpetual tranches compound losses indefinitely during unfavorable conditions with no natural reset.
If the junior tranche is depleted, the senior tranche yield guarantee breaks and senior holders face unexpected losses.
The protocol is early-stage with $3M seed funding and limited track record.
Top Risk Factors
- •Perpetual risk tranching splits USDe yield into senior and junior tranches — if Ethena funding rates go negative for extended periods, junior tranche could be completely wiped out.
- •Direct dependency on Ethena's USDe as foundational yield asset means all tranches inherit Ethena's delta-neutral backing risks.
- •Perpetual tranching without maturity dates means losses compound indefinitely in the junior tranche.
- •Early-stage protocol with $3M seed funding and limited production history.
Risk Score Breakdown
Strata Markets's highest risk area is Interaction Severity (10/20). Here's how each dimension contributes to the overall 43/100 score:
Read the Full Strata Markets Risk Report
This protocol has 2 collapse scenarios. 2 high-severity interaction risks identified. See the full mechanism classification, interaction matrix, and deep-dive recommendations.
View Full Report →Considering an investment?